{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:16:27Z","timestamp":1793175387697,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018720","name":"Advanced Accelerator Applications","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA200551"],"award-info":[{"award-number":["R01 CA200551"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ijrobp.2022.05.037","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T01:54:27Z","timestamp":1654307667000},"page":"725-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6149-345X","authenticated-orcid":false,"given":"Fabrice","family":"Lucien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob J.","family":"Orme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Arafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feven","family":"Abraha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishwor","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Tryggestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorgena","family":"Kosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val J.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene D.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.05.037_bib0001","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1911206","article-title":"Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer","volume":"381","author":"de Wit","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0003","doi-asserted-by":"crossref","unstructured":"Phillips R, Shi WY, Deek M, et al. Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: The ORIOLE phase 2 randomized clinical trial [e-pub ahead of print]. JAMA Oncol. Available at: doi: https:\/\/doi.org\/10.1001\/jamaoncol.2020.0147. Accessed February 20, 2020.","DOI":"10.1001\/jamaoncol.2020.0147"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1200\/JCO.2020.38.6_suppl.10","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial","volume":"3","author":"Ost","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0005","doi-asserted-by":"crossref","unstructured":"Zhang H, Orme JJ, Abraha F, et al. Phase II evaluation of stereotactic ablative radiotherapy (SABR) and immunity in (11)C-choline-PET\/CT-identified oligometastatic castration-resistant prostate cancer [e-pub ahead of print]. Clin Cancer Res. Available at: doi: https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-2510. Accessed September 30, 2021.","DOI":"10.1158\/1078-0432.CCR-21-2510"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0006","doi-asserted-by":"crossref","first-page":"eabb9601","DOI":"10.1126\/science.abb9601","article-title":"Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention","volume":"369","author":"Lennon","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0007","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0008","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0009","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1078-0432.728.11.2","article-title":"Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer","volume":"11","author":"Demaria","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0010","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1158\/2326-6066.CIR-14-0138","article-title":"PD-1 restrains radiotherapy-induced abscopal effect","volume":"3","author":"Park","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0011","doi-asserted-by":"crossref","first-page":"e86014","DOI":"10.1172\/jci.insight.86014","article-title":"T cell Bim levels reflect responses to anti-PD-1 cancer therapy","volume":"1","author":"Dronca","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0012","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00262-020-02587-8","article-title":"Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature","volume":"69","author":"Watanabe","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0013","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103365","article-title":"Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy","volume":"67","author":"Zhou","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0015","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41416-019-0726-9","article-title":"Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival","volume":"122","author":"Nanou","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0016","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.eururo.2016.08.012","article-title":"The detection of androgen receptor splice variant 7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients","volume":"71","author":"Del Re","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0017","doi-asserted-by":"crossref","first-page":"E4473","DOI":"10.1073\/pnas.1802354115","article-title":"Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer","volume":"115","author":"Lee","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001113","article-title":"Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles","volume":"8","author":"Orme","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0019","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: A European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0020","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1538-7836.2012.04683.x","article-title":"Single vs. swarm detection of microparticles and exosomes by flow cytometry","volume":"10","author":"van der Pol","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0021","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0022","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0023","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.ymthe.2020.12.033","article-title":"Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia","volume":"29","author":"Cox","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0024","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-021-21619-0","article-title":"T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors","volume":"12","author":"Yamauchi","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0025","first-page":"1445","article-title":"Prostate-specific membrane antigen: A novel folate hydrolase in human prostatic carcinoma cells","volume":"2","author":"Pinto","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0026","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1764192","article-title":"Comprehensive palmitoyl-proteomic analysis identifies distinct protein signatures for large and small cancer-derived extracellular vesicles","volume":"9","author":"Mariscal","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0027","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S1470-2045(19)30415-2","article-title":"18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial","volume":"20","author":"Calais","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0028","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0029","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2967\/jnumed.118.222844","article-title":"Imaging patients with metastatic castration-resistant prostate cancer using 89Zr-DFO-MSTP2109A anti-STEAP1 antibody","volume":"60","author":"Carrasquillo","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0030","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1200\/JCO.19.00646","article-title":"Phase I study of DSTP3086S, an antibody-drug conjugate targeting six-transmembrane epithelial antigen of prostate 1, in metastatic castration-resistant prostate cancer","volume":"37","author":"Danila","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0031","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.euo.2018.11.007","article-title":"Poor outcomes for patients with metastatic castration-resistant prostate cancer with low prostate-specific membrane antigen (PSMA) expression deemed ineligible for 177Lu-labelled PSMA radioligand therapy","volume":"2","author":"Thang","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0032","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1530\/ERC-18-0226","article-title":"Neuroendocrine differentiation of prostate cancer leads to PSMA suppression","volume":"26","author":"Bakht","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.645623","article-title":"Pulmonary neuroendocrine neoplasms overexpressing epithelial-mesenchymal transition mechanical barriers genes lack immune-suppressive response and present an increased risk of metastasis","volume":"11","author":"Prieto","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102736","article-title":"Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas","volume":"55","author":"Ramakrishnan","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/CMR.0000000000000669","article-title":"Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients","volume":"30","author":"Vera Aguilera","year":"2020","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0036","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/neuonc\/noaa029","article-title":"The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction","volume":"22","author":"Himes","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0037","doi-asserted-by":"crossref","first-page":"eaar2766","DOI":"10.1126\/sciadv.aar2766","article-title":"Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles","volume":"4","author":"Ricklefs","year":"2018","journal-title":"Sci Adv"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0038","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4049\/jimmunol.1003884","article-title":"Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production","volume":"187","author":"Clayton","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0039","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/2326-6066.CIR-19-0449","article-title":"CD73 blockade promotes dendritic cell infiltration of irradiated tumors and tumor rejection","volume":"8","author":"Wennerberg","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0040","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1172\/JCI98060","article-title":"Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma","volume":"128","author":"Huber","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0041","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1368823","article-title":"Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes","volume":"6","author":"Salimu","year":"2017","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108925","article-title":"Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: Mechanism of immune evasion","volume":"9","author":"Lundholm","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0044","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-17-0581","article-title":"Exosomes shuttle TREX1-sensitive IFN-stimulatory dsDNA from irradiated cancer cells to DCs","volume":"6","author":"Diamond","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0045","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.7150\/thno.43539","article-title":"Radiation-induced small extracellular vesicles as \u201ccarriages\u201d promote tumor antigen release and trigger antitumor immunity","volume":"10","author":"Lin","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0046","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1158\/1078-0432.CCR-20-4790","article-title":"Radium-223 treatment increases immune checkpoint expression in extracellular vesicles from the metastatic prostate cancer bone microenvironment","volume":"27","author":"Vardaki","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0047","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2021-675","article-title":"675: Radiotherapy inhibits the antitumor immune response through release of immunosuppressive tumor-derived extracellular vesicles in prostate cancer","volume":"81","author":"Kim","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0048","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050112","article-title":"Rescuing cancer immunity by plasma exchange in metastatic melanoma (ReCIPE-M1): Protocol for a single-institution, open-label safety trial of plasma exchange to clear sPD-L1 for immunotherapy","volume":"12","author":"Davidson","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0049","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1016\/j.clnu.2020.02.027","article-title":"The Mediterranean diet decreases prothrombotic microvesicle release in asymptomatic individuals at high cardiovascular risk","volume":"39","author":"Chiva-Blanch","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0050","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3390\/jcm10051024","article-title":"Prostacyclin analogues inhibit platelet reactivity, extracellular vesicle release and thrombus formation in patients with pulmonary arterial hypertension","volume":"10","author":"G\u0105secka","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijrobp.2022.05.037_bib0051","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/09537104.2018.1557616","article-title":"Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction","volume":"31","author":"Gasecka","year":"2020","journal-title":"Platelets"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622005442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622005442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:00:22Z","timestamp":1759744822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622005442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0360301622005442"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.05.037","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.23.21265236","asserted-by":"object"}]},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}